Gregory D. Casciaro
CEO
- Has over 40 years of experience in the medical device industry, leading companies from clinical development through commercialization and acquisition.
- Served as President and CEO of Access Closure, General Surgical Innovations, Orquest, XTNT, and Foldax Inc., guiding each to successful exits through acquisitions by Cardinal Health, Medtronic, Johnson & Johnson, and Biosensors International.
- Held executive roles at Cardiac Dimensions, Guidant’s Devices for Vascular Intervention division, and North American Instrument Corp.
- Currently serves on the boards of Colospan, Cytokind, and Tulavi Therapeutics, and has held prior board and advisory roles with AngioDynamics, Apama Medical, Dextera Surgical, Kerberos Proximal Solutions, QT Vascular, and RenalPro.
- Holds a BA in Business, Marketing, and Finance from Marquette University.